Key facts
- This page summarizes Jonathan E. Lim's Form 4 filing for Erasca, Inc. (ERAS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 10 Jan 2023, 15:46.
Jonathan E. Lim - 10 Jan 2023 Form 4 Insider Report for Erasca, Inc. (ERAS)
- Reporting relationship
- Chairman & CEO, Director, 10%+ Owner
- Issuer ticker
- ERAS
- Reported as of
- 10 Jan 2023
- Net transaction value
- +$231,420
- SEC form
- 4
- Accepted by SEC
- 10 Jan 2023, 15:46:07 UTC
- Prior SEC filing
- 15 Feb 2023
- Next SEC filing
- 03 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ebun Garner, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jonathan E. Lim filed Form 4 for Erasca, Inc. (ERAS) on 10 Jan 2023.
Change
- Previous filing in this sequence was filed on 15 Feb 2023.
- Current net transaction value: +$231,420.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ERAS
transaction
Common Stock
Purchase
- Transaction value
- $231,420
- Shares
- +60,000
- Change %
- +0.3%
- Price
- $3.86
- Shares after
- 20,256,222
- Date
- 10 Jan 2023
- Ownership
- By Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005
- Footnotes
- F1
ERAS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 11,899,360
- Date
- 10 Jan 2023
- Ownership
- By City Hill, LLC
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005.
Footnote F2
Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.